Skip to main content
Premium Trial:

Request an Annual Quote

Lexogen, Bluebee to Integrate Products for RNA-Seq Data Analysis

NEW YORK (GenomeWeb) – Transcriptomics company Lexogen has partnered with high-performance genomics solutions provider Bluebee to make its QuantSeq analysis pipeline available on Bluebee's cloud-based genomic analysis platform

Lexogen's QuantSeq pipeline supports its QuantSeq 3' expression profiling library preparation kits. The pipeline uses a gene counting approach to analyze transcriptome data, and does not require users to calculate FPKM values making it faster and more straightforward, the company said.

"We believe that implementing a ready-to-use data analysis pipeline on the Bluebee platform is an important step forward in making QuantSeq the most easy-to-use and cost-effective gene expressing profiling workflow available," Lexogen CEO and Founder Alexander Seitz said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.